Back to Results
First PageMeta Content
Pharmaceuticals policy / Intellectual property law / Pharmaceutical industry / Pharmaceutical policy / Essential medicines / Patent / Generic drug / Chemical patent / Health Impact Fund / Pharmaceutical sciences / Pharmacy / Pharmacology


HAI EUROPE RESPONSE Amsterdam, 31st January 2009 This response has been prepared by Health Action International (HAI) Europe. HAI Europe is a non-profit, growing, European network of consumers, public interest NGOs, heal
Add to Reading List

Document Date: 2010-12-09 08:15:39

Open Document

File Size: 158,13 KB

Share Result on Facebook

City

Brussels / Chicago / Paris / /

Continent

Europe / /

IndustryTerm

social insurance systems / pharmaceuticals / healthcare professionals / pharmaceutical industry / pharmaceutical sector / health systems / pharmaceutical / pharmaceutical products / energy / pharmaceutical fees / healthcare quality / /

MedicalCondition

disease / /

MedicalTreatment

medication errors / relaxation / /

Movie

The Big Idea / /

Organization

Congress / Commission on Intellectual Property Rights / Innovation and Public Health / Cambridge university / U.S. Congress / World Health Organization / civil society / International Society of Drug Bulletins / European Commission / European Patent Office / European Union / /

Person

Bernard Sanders / Michel Boldrine / David Levine / /

Position

scientific advisors / Representative / Scientist / /

ProgrammingLanguage

php / /

PublishedMedium

New Scientist / /

RadioStation

WHO 2006 / /

Technology

pdf / /

URL

www.isdbweb.org/pag/documents/ISDB-decl-english.pdf / www.prescrire.org/aLaUne/dossierVMbilanEng.php / www.prescrire.org / www.isdbweb.org / www.europa.eu/enterprise/pharmaceuticals/pharmacos/pharmpack_12_2008/patients/citizens_summary / /

SocialTag